SLVM:NYSESylvamo Corporation Analysis
Data as of 2026-06-21 - not real-time
$39.66
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Sylvamo (SLVM) trades at $39.66, just above its 20‑day SMA (39.42) but below the 50‑day (40.69) and 200‑day (44.46) averages, indicating a short‑term bounce within a longer‑term downtrend. The stock sits near a technical support at $36.97 and faces resistance around $42.26, while the MACD histogram is positive and the MACD line sits above the signal line, offering a bullish signal despite a bearish trend direction and decreasing volume. Volatility is elevated at roughly 38% over the past 30 days, yet beta is modest (0.74), suggesting market moves are muted relative to broader indices. Fundamentally, revenue has contracted 8% YoY, operating margins are near breakeven (0.4%), and the company carries a high debt‑to‑equity ratio of 100.6%, but the forward earnings outlook is strong with EPS projected at $5.58 and a forward P/E of 7.1, far below the current trailing P/E of 15.8. The dividend yield is attractive at 4.54% but the payout ratio is nearly 90%, raising questions about sustainability given negative free cash flow. Analysts rate the stock as a “buy” with a mean target of $59, implying over 40% upside, while the DCF fair value sits at $32.96, suggesting the market is pricing in growth expectations. Overall, the blend of a high dividend, cheap forward valuation, and upside potential is tempered by operational challenges, leverage, and sector cyclicality.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish MACD signal and price near support
- Attractive dividend yield despite sustainability concerns
- Potential short‑term upside toward resistance level
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong forward earnings growth and low forward P/E
- Analyst consensus target price indicating >40% upside
- High dividend yield enhancing total return
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Elevated leverage and declining revenue trends
- Cyclical exposure of the paper industry and regulatory pressures
- Uncertainty around dividend sustainability and free cash flow
Key Metrics & Analysis
Financial Health
Revenue Growth-8.00%
Profit Margin3.10%
P/E Ratio15.8
ROE10.81%
ROA4.80%
Debt/Equity100.61
P/B Ratio1.6
Op. Cash Flow$235.0M
Free Cash Flow$-22875000
Technical Analysis
TrendBearish
RSI48.3
Support$36.97
Resistance$42.26
MA 20$39.42
MA 50$40.69
MA 200$44.46
MACDBullish
VolumeDecreasing
Fear & Greed Index91.46
Valuation
Fair Value$32.96
Target Price$59.00
Upside/Downside48.76%
GradeFair
TypeBlend
Dividend Yield4.54%
Risk Assessment
Beta0.74
Volatility38.44%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.